References in periodicals archive ?
Cross will lead GTBP through NASDAQ capital markets listing process, attract institutional investment and analyst coverage to the company, and guide development of its neurology portfolio and its first TriKE into human clinical testing in 2018.
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.
GT Biopharma Inc (OTCQB: GTBP) (Euronext Paris: GTBP.PA), an immuno-oncology biotechnology company focused on innovative treatments based on the company's proprietary platforms, announced yesterday that it has named Dr John N Bonfiglio as its new director effective 5 July 2018.
(OTCQB: GTBP; Euronext Paris: GTBP.PA) has advanced Dr.
GT Biopharma Inc (OTCQB: GTBP)(Euronext Paris GTBP.PA), a US headquartered immuno-oncology biotechnology company, announced yesterday that the company has promoted Dr Raymond W Urbanski MD, PhD to the position of president and chief medical officer, effective immediately.
GT Biopharma Incorporated (OTCQB: GTBP)(Euronext Paris GTBP.PA), an immuno-oncology biotechnology company focused on innovative treatments based on the company's proprietary platforms, has named Federica O'Brien, CPA as its new director effective immediately, it was reported yesterday.
- Washington, DC-based immuno-oncology biotechnology company GT Biopharma Inc.'s (OTCQB: GTBP; Euronext Paris: GTBP.PA) proof-of-concept clinical trial of GTP-011, a novel treatment for the symptoms of motion sickness, that was initiated in late February 2018 is more than 50% enrolled, the company said.
Acronyms browser ?
Full browser ?
- GTC order
- GTC Orders